Ю. Г. Самойлова

Часть публикаций из профиля, по году от новых к старым. Это не полный список последних работ автора; работы без года — в конце.

• ASSESSMENT OF THE RELATIONSHIPS OF ASPROSIN WITH CHANGES IN THE CARDIOVASCULAR AND RESPIRATORY SYSTEMS IN CHILDREN AND ADOLESCENTS AGED 12–17 YEARS WITH OBESITY AND NORMAL BODY WEIGHT: A CROSS-SECTIONAL COMPARATIVE STUDY2026
• Blood plasma adipomyokine levels and proteinaseinhibitory activity in sarcopenic obesity2026
• Ultrasound assessment of skeletal muscles in patients with metabolic diseases and in healthy individuals over 45 years of age2026
• Diabetic fetopathy – pathogenesis, prognosis, perinatal and neonatal outcomes2026
• Expression of microRNAs in blood plasma and saliva in women with gestational diabetes and its relationship with biochemical parameters2026
• A randomized clinical trial of the efficacy and safety of sitagliptin as initial oral therapy in youth with type 2 diabetes2021 · аннотациясвернуть

  OBJECTIVE: To assess the efficacy and safety of DPP-4 inhibition with sitagliptin in youth with type 2 diabetes (T2D). STUDY DESIGN: This was a 54-week, double-blind, randomized, controlled clinical trial evaluating the…

• Efficacy and safety of the addition of sitagliptin to treatment of youth with type 2 diabetes and inadequate glycemic control on metformin without or with insulin2021 · аннотациясвернуть

  OBJECTIVE: To assess the efficacy and safety of sitagliptin in youth with type 2 diabetes (T2D) inadequately controlled with metformin ± insulin. STUDY DESIGN: Data were pooled from two 54-week, double-blind,…

• PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes2019 · аннотациясвернуть

  OBJECTIVE This trial compared the efficacy and safety of the first oral glucagon-like peptide 1 (GLP-1) receptor agonist, oral semaglutide, as monotherapy with placebo in patients with type 2 diabetes managed by diet…